Stocks To Buy Now

Blog


DGE’S 12th Advancing Women’s Leadership in Pharma & Healthcare Fosters Collaborations

Women executives, professionals, influencers, solution providers, government organizations, investors, and those interested or involved in the pharma, biotech, medical device, and other healthcare systems, are invited to attend the 12th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare conference being held at the Hotel Tampa Riverwalk from March 25-27, 2024, in Tampa, FL.

As women expand their leadership roles to move up in their career paths, this summit offers them an important platform to seek and impart knowledge. They can connect with industry peers and leaders for meaningful connections. Top women pharmaceutical and biotechnology professionals will share their success journeys at the DGE forum to help and inspire aspiring women leaders.

Reasons to attend:

  • Get know-how on the latest topics of importance in the healthcare spectrum
  • Learn ways to close the gender disparity gap and empower everyone’s roles
  • Understand the strategies to bring the best work culture and leadership skills to your organization
  • Learn the best business secrets from veteran women leaders
  • Connect with imminent industry leaders for collaborations and prospects
  • Find your voice and bring about a change
  • Aspiring women professionals can ally, learn, and support their colleagues

The event will feature a keynote speaker panel focused on overcoming challenges, empowering women, and speaking about the importance of allyship in the workplace. It will also be an educational session on breaking through the glass ceiling. Experts will speak about the importance of executive presence and how it enables women empowerment to cultivate personal branding and leadership goals. This is an in-person as well as a live-streaming program.

To know more, please visit (https://nnw.fm/BjcPn)

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape

May 9, 2025

A Market Demanding Safer Opioid Solutions The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers […]

Rotate your device 90° to view site.